Cerebral Infarction Clinical Trial
Official title:
Treating Apoplectic Sequela With Acupuncture: a Randomized Controlled Study
The purpose of this study is to evaluate the therapeutic effect of acupuncture method of "Xing Nao Kai Qiao" for paralysis as an apoplectic sequela in a multicenter randomized and controlled clinical trial and to compare the efficacy between acupuncture and rehabilitation therapy. In addition, evaluating the trial in the view of medical economics.
Status | Recruiting |
Enrollment | 288 |
Est. completion date | October 2010 |
Est. primary completion date | October 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 40 Years to 75 Years |
Eligibility |
Inclusion Criteria: 1. Cerebral infarction diagnosed according to the diagnostic standard of western medicine 2. Apoplexy diagnosed according to the diagnostic standard of traditional Chinese medicine for apoplexy 3. Cerebral vascular accident occured in the internal carotid artery system which was verified by cerebral CT or MRI 4. The incidence of apoplexy less than twice and the time of onset 15~3 months 5. Age: 40-75 years, non-limited gender 6. NDS score of limb functional defect =10 7. The patient was alert and the vital signs are stable 8. Participant signed the informed consent form Exclusion Criteria: 1. TIA or RIND 2. The nerve function defect induced by the cerebral tumor, trauma, parasitic diseases, heart disease and metabolic disorder or hemorrhagic cerebrovascular disease 3. Pregnant or breast-feeding women 4. Complicated with severe primary disease in heart, liver, kidney and hematology system or psychopath |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
China | First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (TCM) | Tianjin | Tianjin |
Lead Sponsor | Collaborator |
---|---|
Tianjin University of Traditional Chinese Medicine |
China,
Shiflett SC. Does acupuncture work for stroke rehabilitation: what do recent clinical trials really show? Top Stroke Rehabil. 2007 Jul-Aug;14(4):40-58. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Score of neurological defect | before treatment, after the first treatment, 7, 14, 28days after treatment and follow up at 6 months after treatment. | Yes | |
Secondary | Visualized anologue score | before treatment, after the first treatment, 7, 14, 28days after treatment and follow up at 6 months after treatment. | Yes | |
Secondary | Spasm evaluation | before treatment, after the first treatment, 7, 14, 28days after treatment and follow up at 6 months after treatment. | Yes | |
Secondary | Safety evaluation | before treatment, after the first treatment, 7, 14, 28days after treatment and follow up at 6 months after treatment. | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02551003 -
Neuroprotective Effect of Autologous Cord Blood Combined With Therapeutic Hypothermia Following Neonatal Encephalopathy
|
Phase 1/Phase 2 | |
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Completed |
NCT00684515 -
Trial to Assess the Safety of Vorapaxar in Japanese Subjects With Cerebral Infarction (P05005; MK-5348-017)
|
Phase 2 | |
Not yet recruiting |
NCT04082091 -
Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular Prevention
|
||
Completed |
NCT01915368 -
Determining Optimal Post-Stroke Exercise (DOSE)
|
N/A | |
Terminated |
NCT01684462 -
The Efficacy and Safety Study of ALbumin Therapy in Acute Ischemic Stroke
|
Phase 2 | |
Completed |
NCT00386191 -
Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment
|
Phase 4 | |
Completed |
NCT00004734 -
Vitamin Therapy for Prevention of Stroke
|
Phase 3 | |
Completed |
NCT02684825 -
Detection of Silent Atrial Fibrillation aFter Ischemic StrOke
|
N/A | |
Completed |
NCT02248233 -
Nimodipine for Treating Acute Massive Cerebral Infarction
|
Phase 4 | |
Completed |
NCT02963545 -
TSK (Tryptophan - Serotonin - Kynurenine) Biomarkers Assessment in Stroke
|
N/A | |
Completed |
NCT02511249 -
Early Determinants of Multidimensional Outcome at School Age After Neonatal Arterial Ischemic Stroke
|
N/A | |
Completed |
NCT02101606 -
Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke
|
Phase 2 | |
Completed |
NCT00829361 -
Stroke Telemedicine for Arizona Rural Residents Trial
|
N/A | |
Completed |
NCT01500421 -
Safty and Feasibility Study of Therapeutic Cooling in Acute Ischemic Stroke (COOLAID Øresund)
|
Phase 2 | |
Terminated |
NCT00331890 -
ICTUS Study: International Citicoline Trial on Acute Stroke
|
Phase 3 | |
Not yet recruiting |
NCT04696523 -
Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage
|
Phase 2 | |
Completed |
NCT03741400 -
Virtual Reality Glove for Hand and Arm Rehabilitation After Stroke
|
N/A | |
Recruiting |
NCT04908241 -
Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL-RCT)
|
N/A |